Sentinel Node With Ultrasound Contrast in Melanoma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00370136|
Recruitment Status : Completed
First Posted : August 30, 2006
Last Update Posted : June 18, 2008
The purpose is to evaluate,in 20 patients, if the sentinel node(s) in melanoma can be detected by lymph contrast ultrasound. In comparing the patients will also get lymph-scintigraphy and sentinel node detection wiht blue dye.
The goal is to improve the method for detecting sentinel node(s) in melanoma.
|Condition or disease||Intervention/treatment||Phase|
|Malignant Melanoma||Drug: ultrasound contrast||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Sentinel Node Diagnostics With Ultrasound Contrast in Melanoma|
|Study Start Date :||August 2006|
|Primary Completion Date :||March 2008|
|Study Completion Date :||April 2008|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00370136
|Copenhagen univercity hospital, Department of Radiology, section of ultrasound|
|Copenhagen, Denmark, 2100|
|Principal Investigator:||Michael B Nielsen, MDSc||Department of Radiology, section ultrasound|